Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Remimazolam on Delirium After Cardiac Surgery
NCT07265128Phase 4Not yet recruiting
- Sponsor
- Yonsei University
- Start
- Dec 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in postoperative delirium (POD), sponsored by Yonsei University. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07265128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07265128.